Ionis, AstraZeneca get FDA approval for rare genetic disease treatment
Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the U.S. Food and Drug Administration for ...
Read moreTag: Genetic Disorders
Merck to buy Prometheus Biosciences for $10.8 billion
Drug maker Merck & Co. Inc. announced Sunday a deal to acquire Prometheus Biosciences Inc. for $200 a share, or ...
Read more
